ACCESSION: MSBNK-SMB_Measured-HSA015P0158006
RECORD_TITLE: Characterized; N,N-dibutylformamide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 45
COMMENT: RAW_SPEC {'EL03_pos_8870': {'bp': 170111.0, 'sum': 676746.0}, 'EL06_pos_9029': {'bp': 104762.0, 'sum': 627660.0}, 'EL03_pos_8744': {'bp': 155431.0, 'sum': 662062.0}, 'EL03_pos_8573': {'bp': 148413.0, 'sum': 649625.0}, 'EL05_pos_9040': {'bp': 103607.0, 'sum': 672119.0}, 'EL22_pos_9959': {'bp': 109521.0, 'sum': 702578.0}, 'EL03_pos_8633': {'bp': 162270.0, 'sum': 665698.0}, 'EL19_pos_9047': {'bp': 106072.0, 'sum': 678106.0}, 'EL03_pos_8690': {'bp': 150040.0, 'sum': 662673.0}, 'EL19_pos_9290': {'bp': 111286.0, 'sum': 756032.0}, 'EL19_pos_9231': {'bp': 103945.0, 'sum': 718776.0}, 'EL21_pos_8968': {'bp': 98114.0, 'sum': 629369.0}, 'EL03_pos_8801': {'bp': 159178.0, 'sum': 685365.0}, 'Blanc1-pos_8643': {'bp': 151401.0, 'sum': 851656.0}, 'Blanc1-pos_9147': {'bp': 146000.0, 'sum': 844510.0}, 'EL22_pos_9053': {'bp': 122183.0, 'sum': 700499.0}, 'EL02_pos_9281': {'bp': 115792.0, 'sum': 719908.0}, 'EL19_pos_9171': {'bp': 110208.0, 'sum': 729181.0}, 'EL02_pos_9101': {'bp': 99644.0, 'sum': 664213.0}, 'Blanc1-pos_9087': {'bp': 149202.0, 'sum': 860458.0}, 'EL22_pos_9352': {'bp': 120628.0, 'sum': 805642.0}, 'EL19_pos_8980': {'bp': 115484.0, 'sum': 693703.0}, 'EL06_pos_9148': {'bp': 103742.0, 'sum': 728929.0}, 'EL03_pos_8925': {'bp': 166459.0, 'sum': 772625.0}, 'EL03_pos_8489': {'bp': 165339.0, 'sum': 698251.0}, 'Blanc1-pos_8764': {'bp': 150328.0, 'sum': 847074.0}, 'EL02_pos_8981': {'bp': 128042.0, 'sum': 729753.0}, 'EL22_pos_8993': {'bp': 126532.0, 'sum': 692108.0}, 'EL22_pos_9171': {'bp': 123082.0, 'sum': 761499.0}, 'EL02_pos_9220': {'bp': 119305.0, 'sum': 728089.0}, 'EL05_pos_9159': {'bp': 112559.0, 'sum': 739504.0}, 'Blanc1-pos_9201': {'bp': 156688.0, 'sum': 861708.0}, 'Blanc1-pos_8525': {'bp': 141385.0, 'sum': 803996.0}, 'EL22_pos_9231': {'bp': 115400.0, 'sum': 731692.0}, 'EL02_pos_9041': {'bp': 115153.0, 'sum': 697807.0}, 'Blanc1-pos_9027': {'bp': 143150.0, 'sum': 849463.0}, 'EL02_pos_9161': {'bp': 112808.0, 'sum': 719246.0}, 'Blanc1-pos_8583': {'bp': 138779.0, 'sum': 831469.0}, 'Blanc1-pos_8897': {'bp': 131880.0, 'sum': 814725.0}, 'EL22_pos_9293': {'bp': 115760.0, 'sum': 735526.0}, 'EL12_pos_8998': {'bp': 106243.0, 'sum': 655955.0}, 'Blanc1-pos_8823': {'bp': 136040.0, 'sum': 814313.0}, 'EL22_pos_9111': {'bp': 105916.0, 'sum': 662390.0}, 'Blanc1-pos_8704': {'bp': 155160.0, 'sum': 861932.0}, 'Blanc1-pos_8969': {'bp': 132824.0, 'sum': 780255.0}}
COMMENT: RETENTION_TIME_STDEV 0.468
COMMENT: PRECURSOR_M/Z_RAW 158.154114
COMMENT: PRECURSOR_M/Z_STDEV 0.000046
COMMENT: PRECURSOR_IN_MS1 mz 158.153936; int 54.784; delta(ppm) 0.920375
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.000; C9H19NO; [M+H]+; delta(ppm) -0.000000
COMMENT: PROPOSED_MF MS-FINDER 3.311; C9H19NO; [M+H]+; delta(ppm) -0.004220
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.620; C9H19NO; [M+H]+; delta(ppm) -0.004220
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H19NO; [M+H]+; delta(ppm) -0.004220
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.069; C9H19NO; [M+H]+; delta(ppm) -0.004220
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.124; C7H17N4; [M+H]+; delta(ppm) 8.485452
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H19NO; [M+H]+; delta(ppm) -0.004220
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.996; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; CCCCN(CCCC)C=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.660; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)C)CC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.640; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; CCN(CC)C(=O)CC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.583; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; CC1(CCCC(N1O)(C)C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.571; JFKADWNYKAZYSD-UHFFFAOYSA-N; [M+H]+; OC1CCCNCCCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.308; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.290; HHONKRXRGXJUCW-MDZDMXLPSA-N; [M+H]+; UNPD143954
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.290; UYPVPBFQQUHERE-KTKRTIGZSA-N; [M+H]+; UNPD112415
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.290; WIXWMTMSISERBV-MDZDMXLPSA-N; [M+H]+; UNPD65027
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.268; ICMNKCCFRUPZCU-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.267; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.267; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.221; KYEKSZMDGACCQD-BRJQIKQINA-N; [M+H]+; UNPD32313
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.215; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; CNP0428582
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.196; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; 1-Hydroxy-2-Amino-3-Cyclohexylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.186; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; UNPD76164
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.165; DVJHWTLBEYCZJZ-SSEDHECMNA-N; [M+H]+; UNPD102291
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.165; ZRXAUOSECWYDMA-BRJQIKQINA-N; [M+H]+; UNPD140973
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.158; JOHKCJPJMSCFBX-BRJQIKQINA-N; [M+H]+; UNPD184071
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.151; MSYUGRASNIEUCW-MDWBIBFBNA-N; [M+H]+; UNPD26154
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.149; YWFHDUFNGSJLTL-VIFPVBQESA-N; [M+H]+; N-1-Methylheptylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; JFKADWNYKAZYSD-UHFFFAOYSA-N; [M+H]+; cis-azacyclodecan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; CNP0428582
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; YWFHDUFNGSJLTL-VIFPVBQESA-N; [M+H]+; N-1-Methylheptylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; UNPD76164
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; HHONKRXRGXJUCW-MDZDMXLPSA-N; [M+H]+; UNPD143954
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; UYPVPBFQQUHERE-KTKRTIGZSA-N; [M+H]+; UNPD112415
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; WIXWMTMSISERBV-MDZDMXLPSA-N; [M+H]+; UNPD65027
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; ICMNKCCFRUPZCU-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; DVJHWTLBEYCZJZ-SSEDHECMNA-N; [M+H]+; UNPD102291
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; JOHKCJPJMSCFBX-BRJQIKQINA-N; [M+H]+; UNPD184071
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; MSYUGRASNIEUCW-MDWBIBFBNA-N; [M+H]+; UNPD26154
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; ZRXAUOSECWYDMA-BRJQIKQINA-N; [M+H]+; UNPD140973
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; JFKADWNYKAZYSD-UHFFFAOYSA-N; [M+H]+; cis-azacyclodecan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.755; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; 1-Hydroxy-2-Amino-3-Cyclohexylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.618; KYEKSZMDGACCQD-BRJQIKQINA-N; [M+H]+; UNPD32313
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.028; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.162; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.829; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; nonanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.517; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.281; JNSUUJLFWBSBME-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpiperidin-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.266; NTYICSDTCGMBQM-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-methylpropyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; HFHPBMVMXFZJNO-UHFFFAOYSA-N; [M+H]+; 1-(cyclohexylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; QQBFZTKZYQFNHA-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.205; AOFZLQPFVNKHSR-UHFFFAOYSA-N; [M+H]+; 2-ethylheptanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.203; NBXAPOVFSGOATB-UHFFFAOYSA-N; [M+H]+; N-(2,4,4-trimethylpentan-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.203; BJXJCAMLWINIQS-UHFFFAOYSA-N; [M+H]+; N-(2,2,4,4-tetramethylpentan-3-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; HJXLFVPMOMDPNR-UHFFFAOYSA-N; [M+H]+; 2-ethyl-N-methylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; AGCBBXPWJMYJGB-UHFFFAOYSA-N; [M+H]+; 2,2,4,4-tetramethylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; YZXDDIUXFGJNJN-UHFFFAOYSA-N; [M+H]+; 1-(dimethylamino)-4,4-dimethylpentan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; MXZJHUFPDPEROD-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; HJVRJOCKISGMLI-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpropyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; MLSOMJXYSKJLAZ-UHFFFAOYSA-N; [M+H]+; 4-tert-butylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; KWJAQKNXBIWDPO-UHFFFAOYSA-N; [M+H]+; [2-(2-methylpropyl)pyrrolidin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; SCFYAMLANWTHKN-UHFFFAOYSA-N; [M+H]+; 2-tert-butyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; HPKNTDCRBSNGEA-UHFFFAOYSA-N; [M+H]+; (2-tert-butyloxolan-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; RPPGMZVKEWPDGB-SECBINFHSA-N; [M+H]+; (3R)-3-(3-methylbutoxy)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; WBYHBNSUFOOVLX-UHFFFAOYSA-N; [M+H]+; 1-(cyclopropylamino)-3,3-dimethylbutan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; RGBLJJXXWNGXMA-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpropyl)oxan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; JIPFBCZZZJBRER-SFYZADRCSA-N; [M+H]+; [(2S,3R)-2-tert-butyloxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; JBLNCKGCJCTSOJ-UHFFFAOYSA-N; [M+H]+; 7-tert-butyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; GIGKHNPRTHOMSB-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-2-methylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; GRGNJBKJCVOFEO-UHFFFAOYSA-N; [M+H]+; 5-(diethylamino)pentan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.190; VQCDOLZOAYIDQJ-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropoxy)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.190; XGPJZKQGJWZWIM-UHFFFAOYSA-N; [M+H]+; 4-butoxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; VWXSCKOHAKPRKK-MRVPVSSYSA-N; [M+H]+; (2R)-2-[(2-methylpropan-2-yl)oxymethyl]pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; RSMXSKJUTTWWLA-UHFFFAOYSA-N; [M+H]+; 3-[(2-methylpropan-2-yl)oxy]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; PTPWBTAUDLQZKV-UHFFFAOYSA-N; [M+H]+; N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; KBYASNMQYNVACB-HTQZYQBOSA-N; [M+H]+; (1R,2R)-2-[(2-methylpropan-2-yl)oxy]cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; SREGPVVWLSESFC-UHFFFAOYSA-N; [M+H]+; 4-butan-2-yloxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; FVAFFSLNBGWGEQ-UHFFFAOYSA-N; [M+H]+; [3-[(2-methylpropan-2-yl)oxy]cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; BCPWKBKIOFUMTD-JGVFFNPUSA-N; [M+H]+; [(1S,2R)-2-[(2-methylpropan-2-yl)oxy]cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; OVTMCBIZTDPCGB-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-pyrrolidin-1-ylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; SOHAWBMOFPPYDC-UHFFFAOYSA-N; [M+H]+; 2-methyl-4-pyrrolidin-1-ylbutan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; DAXQBFKMRFISCP-SECBINFHSA-N; [M+H]+; (2S)-3-methyl-2-pyrrolidin-1-ylbutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; KXFQCMKAQXWNSL-UHFFFAOYSA-N; [M+H]+; 3-(azepan-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; SSBJNXYJAHFKJQ-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-piperidin-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; YECWYDXDKXESES-UHFFFAOYSA-N; [M+H]+; 2-(3-methoxypropyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; JOHKCJPJMSCFBX-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; RHULHUMGLDCWCP-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; PRQUQLLKNBALCZ-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; XMXJFWWVIWEVQJ-UHFFFAOYSA-N; [M+H]+; 3-(2-methoxyethyl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; (2S)-2-amino-3-cyclohexylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; DSDSZHUBHNTFNX-UHFFFAOYSA-N; [M+H]+; 2-[cyclohexyl(methyl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; ZRXXYJYSVHQULF-UHFFFAOYSA-N; [M+H]+; 3-cyclohexyloxypropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; DFOAUWHTDKZVPW-UHFFFAOYSA-N; [M+H]+; 3-(cyclohexylamino)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; WLNWJJLFZFNSAW-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)cyclohexanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; LBKGSNPSDIYPBE-UHFFFAOYSA-N; [M+H]+; 2-[(dimethylamino)methyl]cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; OWSKYYMCKRWOEA-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-N-ethoxymethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; CZRCDRZKRJGHGB-UHFFFAOYSA-N; [M+H]+; 1-[(dimethylamino)methyl]cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; MLZLVMCHKUSCQC-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-3,3-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; NXBJSUOOKXVSFX-IUCAKERBSA-N; [M+H]+; (1S,2S)-2-(propan-2-ylamino)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; INIIZXNMNKIITF-UHFFFAOYSA-N; [M+H]+; 3-amino-3-cyclohexylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; BJYNTHACALEJGC-UHFFFAOYSA-N; [M+H]+; 2-(3-aminopropyl)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; IGNIQYQEYLIVJD-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-4,4-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; NCMLFEXUCUKLTC-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-2-(methylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; UKTBJVVCFQRSAE-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)-3-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; NCHRTQDYCCCDDN-UHFFFAOYSA-N; [M+H]+; (1-methoxycycloheptyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; FVKOSULHWWBPPZ-UHFFFAOYSA-N; [M+H]+; (1-methoxy-3-methylcyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; WVAVJUUVJFWPJM-UHFFFAOYSA-N; [M+H]+; 2-(2-methylcyclohexyl)oxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; UMQVSWNKTFNAEL-RKDXNWHRSA-N; [M+H]+; (1R,2R)-2-ethoxycycloheptan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; MOOLCUJJTYOPDX-UHFFFAOYSA-N; [M+H]+; 1-(methylaminomethyl)cycloheptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; QXCAMZSWINJGLA-UHFFFAOYSA-N; [M+H]+; (1-amino-4-ethylcyclohexyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; VGNDMJNNNYAABM-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-3-cyclopentylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; KBZZKXGGRZDEOS-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)-2-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; NNJGMUPZEXDYDP-UHFFFAOYSA-N; [M+H]+; 1-(2-aminoethyl)cycloheptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; CMAXLAQPCZHYRB-UHFFFAOYSA-N; [M+H]+; 6-methoxy-2,2-dimethylcyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; GJPRLMIJSXDNSB-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-4,4-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; YPNXWVGJCIUHFJ-UHFFFAOYSA-N; [M+H]+; 2-(1-methoxycyclohexyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; RPCMANPQGDZWBI-UHFFFAOYSA-N; [M+H]+; 2-(5,5-dimethyloxan-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; YHARJABDPGDVSR-RKDXNWHRSA-N; [M+H]+; [(1S,2R)-2-(dimethylamino)cyclohexyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; OJHFXJYQQCFGOQ-UHFFFAOYSA-N; [M+H]+; 2-(3,3-dimethyloxan-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; LZBCDMOWRUZUJE-UHFFFAOYSA-N; [M+H]+; N-methyl-2-(1-methylcyclopentyl)oxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; COOJVMHRVYJJAH-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-(oxan-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; PCQWQLYLZRJDLA-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; CHHKBQOLWAUFPM-UHFFFAOYSA-N; [M+H]+; N-ethyl-2,2-dimethyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; HTNALYQLVYDBSI-UHFFFAOYSA-N; [M+H]+; (2-propan-2-yloxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; AAHIYAKUVPMLMX-UHFFFAOYSA-N; [M+H]+; 3-(diethylamino)-2,2-dimethylpropanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; OKDIVZDZOAXDQB-UHFFFAOYSA-N; [M+H]+; [1-(diethylaminomethyl)cyclopropyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; CGCDPLMLTIOADD-UHFFFAOYSA-N; [M+H]+; N-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; KAACLWQGBIEOGR-UHFFFAOYSA-N; [M+H]+; 3-propylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; MSRLXJWEQJQIJQ-UHFFFAOYSA-N; [M+H]+; N-(2-propylpentyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; JKUFWRDSSYNRPE-NTMALXAHSA-N; [M+H]+; (NZ)-N-(3-propylhexan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; RDFVLCNOBZQYRK-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-propan-2-yloxycyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.881; SWHGGGURSFRRNJ-UHFFFAOYSA-N; [M+H]+; [1-(1-amino-2-methylpropyl)cyclobutyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; LZXLHLSTUPFULX-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; FLKOJXQVRBGEES-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; MVEHLQBURCSCQA-UHFFFAOYSA-N; [M+H]+; 1-(1-ethylpiperidin-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; AUXMJHJWQFKJDJ-UHFFFAOYSA-N; [M+H]+; [1-(2-ethoxyethyl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; CHXUMKPVYHZWSN-UHFFFAOYSA-N; [M+H]+; (3-propan-2-ylpiperidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; MZUBANKASMUHHF-UHFFFAOYSA-N; [M+H]+; 4-propoxycyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; RJRRWCVYXLMUJD-UHFFFAOYSA-N; [M+H]+; 4-amino-1-propan-2-ylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; PIOUVJMSPKFDJZ-UHFFFAOYSA-N; [M+H]+; 3-methoxy-2,2,4,4-tetramethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; WKEDXGRBZXNJEX-UHFFFAOYSA-N; [M+H]+; 3-propan-2-yloxycyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; VIBZEOYMXOCRTD-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yloxycyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.806; NBXAPOVFSGOATB; [M+H]+; tert-Octylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.084; QZMQDHNCNUGQSO; [M+H]+; Valimyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.603; BJXJCAMLWINIQS; [M+H]+; 2,2,4,4-Tetramethyl-3-pentanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.217; NTYICSDTCGMBQM; [M+H]+; n,n-diisobutylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.090; AGCBBXPWJMYJGB; [M+H]+; 2,2,4,4-Tetramethylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.151; MSRLXJWEQJQIJQ; [M+H]+; n-(2-propylpentyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.904; MXZJHUFPDPEROD; [M+H]+; 2-Ethyl-5-methylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.342; ICMNKCCFRUPZCU; [M+H]+; Sec-Butyl-Propylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.949; HJXLFVPMOMDPNR; [M+H]+; 2-Ethyl-N-methylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.612; VUZNLSBZRVZGIK; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.527; VDVUCLWJZJHFAV; [M+H]+; Lastar A
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.950; VQCDOLZOAYIDQJ; [M+H]+; 4-(2-methylpropoxy)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.001; CGCDPLMLTIOADD; [M+H]+; N-Methyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.387; KAACLWQGBIEOGR; [M+H]+; 3-Propylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.276; OCRWQOBBCGSFAT; [M+H]+; Oprea1_131312
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.740; HFHPBMVMXFZJNO; [M+H]+; 1-Cyclohexylaminopropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.834; YWFHDUFNGSJLTL; [M+H]+; N-[(2S)-octan-2-yl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.546; JKUFWRDSSYNRPE; [M+H]+; 3-Propyl-2-hexanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.726; DVJHWTLBEYCZJZ; [M+H]+; 1-(6-methyl-2-piperidyl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.654; NCMLFEXUCUKLTC; [M+H]+; N-Methyl-2-cyclohexylethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.410; AOFZLQPFVNKHSR; [M+H]+; 2-Ethylheptanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.652; WIXWMTMSISERBV; [M+H]+; Nonanal, oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.177; NZMAJUHVSZBJHL; [M+H]+; Dibutylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.408; GRGNJBKJCVOFEO; [M+H]+; Novalketone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.767; GHLZUHZBBNDWHW; [M+H]+; Nonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.699; QEOQBRVOQFQFEF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.709; UYPVPBFQQUHERE; [M+H]+; nonan-3-one oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.764; OYKSDWPYPAQPRX; [M+H]+; Ambcb9070586
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.060; WCPJVPPCOMEVQR; [M+H]+; 4-(2-Methylaminoethyl)cyclohexanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.204; HHONKRXRGXJUCW; [M+H]+; ACMC-20mgno
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.966; ZRXAUOSECWYDMA; [M+H]+; (2R)-1-[(2S)-piperidin-2-yl]butan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.915; QWDRYURVUDZKSG; [M+H]+; Ambcb4034760
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.062; HJVRJOCKISGMLI; [M+H]+; 2-(2-methylpropyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.832; NAXTXBAUPVGPMV; [M+H]+; 2,5-Dimethylpyrrolidine-1-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.646; CDTAOSZEZXQTRJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.298; HZNNAMZSTNNZPR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.532; JNSUUJLFWBSBME; [M+H]+; 1-Piperidinepropanol, 2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.004; RHULHUMGLDCWCP; [M+H]+; 1-Azepan-1-Yl-Propan-2-Ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.526; KXFQCMKAQXWNSL; [M+H]+; Ambcb4010638
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.847; SSBJNXYJAHFKJQ; [M+H]+; 1-Piperidineethanol, a,a-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.417; UISZWADDKPLXNW; [M+H]+; 1-Butylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.610; KYEKSZMDGACCQD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -314.073; JOHKCJPJMSCFBX; [M+H]+; 1-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -342.407; CZRCDRZKRJGHGB; [M+H]+; Cyclohexanol, 1-[(dimethylamino)methyl]-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.448; MSYUGRASNIEUCW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.328; NBXAPOVFSGOATB; [M+H]+; tert-Octylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -32.718; NZMAJUHVSZBJHL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -114.484; NTYICSDTCGMBQM; [M+H]+; N,N-Bis(2-methylpropyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.673; BPDCZYLPNNLOBD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.517; MSRLXJWEQJQIJQ; [M+H]+; Formamide, N-(2-propylpentyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.808; QZMQDHNCNUGQSO; [M+H]+; Isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.253; GRGNJBKJCVOFEO; [M+H]+; 5-Diethylamino-2-pentanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.031; NBXAPOVFSGOATB; [M+H]+; N-(1,1,3,3-Tetramethylbutyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.008; JKUFWRDSSYNRPE; [M+H]+; 3-Propyl-2-hexanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.571; BJXJCAMLWINIQS; [M+H]+; 2,2,4,4-tetramethyl-N-oxidopentan-3-imine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.444; XGPJZKQGJWZWIM; [M+H]+; 4-Butoxypiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.851; NZMAJUHVSZBJHL; [M+H]+; nan
COMMENT: CONFIDENCE Level 3: Tentative candidate, N,N-dibutylformamide, NZMAJUHVSZBJHL-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (2);
CH$NAME: N,N-dibutylformamide
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H19NO
CH$EXACT_MASS: 157.146664
CH$SMILES: CCCCN(CCCC)C=O
CH$IUPAC: InChI=1S/C9H19NO/c1-3-5-7-10(9-11)8-6-4-2/h9H,3-8H2,1-2H3
CH$LINK: INCHIKEY NZMAJUHVSZBJHL-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:12975
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 14.507
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 158.153940
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-5900000000-71a0b3ac57edceb3cbdd
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544222 35.5273 55.055130 0.8719 7.79 0.0664 45 f{C4H7}/3.55ppm,p-C5H13N1O1
  55.9346683 314.6383 55.935380 0.4112 85.39 -0.2785 45 ?
  57.0701335 110.5232 57.070850 0.6834 25.01 0.8278 45 f{C4H9}/4.50ppm,p-C5H11N1O1
  69.0699470 32.8350 69.070690 1.2451 9.24 0.1695 43 f{C5H9}/1.02ppm,p-C4H11N1O1
  70.0288168 45.0665 70.029560 0.7997 13.83 0.2727 39 f{C3H4N1O1}/1.09ppm,p-C6H16
  71.9293870 31.2601 71.930130 1.0983 8.67 -0.1247 39 ?
  72.0445071 335.7210 72.045250 0.3331 89.56 0.2968 45 f{C3H6N1O1}/1.62ppm,p-C6H14
  72.9372376 142.4329 72.937980 0.6581 41.07 -0.2810 45 ?
  74.9308647 43.8205 74.931605 0.7474 13.78 0.0533 32 ?
  74.9376497 179.0432 74.938390 0.7339 67.47 0.1818 45 ?
  75.0553499 30.1640 75.056090 1.1591 9.85 -0.1882 42 ?
  75.9354412 32.0621 75.936180 0.9745 9.36 -0.1383 40 ?
  76.9329830 72.9132 76.933720 0.9359 29.90 0.2497 45 ?
  78.9970877 104.6743 78.997820 0.9367 23.32 0.1257 45 ?
  89.9397936 36.4058 89.940480 1.1674 11.77 -0.1871 42 ?
  90.9476296 55.0846 90.948310 1.0226 14.01 -0.0085 44 ?
  91.0542103 23.0435 91.054890 1.4277 4.74 0.1832 33 f{C7H7}/-0.18ppm,p-C2H13N1O1
  92.9480475 28.6829 92.948715 1.3986 11.97 0.0444 32 ?
  97.0076123 146.1426 97.008250 0.5979 29.37 -0.0609 45 f{C8H1}/3.46ppm,p-C1H19N1O1
  97.0647228 31.8978 97.065360 1.0921 8.01 -0.0183 43 f{C6H9O1}/-0.71ppm,p-C3H11N1
  102.0913466 222.6364 102.091940 0.5681 56.48 0.8992 45 f{C5H12N1O1}/0.06ppm,p-C4H8
  106.9919467 147.0988 106.992490 0.7571 32.41 0.0882 44 ?
  107.9504134 39.5535 107.950950 1.0375 12.34 -0.0657 43 ?
  113.9636730 34.4350 113.964165 1.2636 9.03 0.2841 40 ?
  114.0549837 105.8402 114.055475 0.8417 28.81 0.4028 44 ?
  115.9640546 211.7658 115.964530 0.5346 81.19 0.1966 45 ?
  117.0698141 40.4450 117.070280 1.2130 10.62 -0.0684 43 f{C9H9}/-0.53ppm,p-H11N1O1
  117.9595320 83.6243 117.959990 1.1784 35.22 0.1373 44 ?
  125.0025203 232.3219 125.002910 0.5680 51.39 -0.1028 45 f{C9H1O1}/2.63ppm,p-H19N1
  125.9610504 33.0464 125.961430 1.2067 9.58 -0.0583 35 ?
  128.9507833 172.1385 128.951130 0.7135 46.70 -0.2404 45 ?
  133.9745829 44.4095 133.974870 1.2316 17.52 0.3221 39 ?
  135.9453367 81.3208 135.945600 1.2579 25.02 -0.1443 45 ?
  146.9613175 84.0275 146.961610 1.0071 26.22 -0.3225 34 ?
  153.9559084 45.3883 153.956220 0.9678 12.61 -0.0680 39 ?
  157.1335896 27.2558 157.133910 1.5910 7.54 -0.1782 35 ?
  158.0964369 999.0000 158.096760 0.3416 0.00 0.1353 45 ?
  158.1539267 463.6778 158.154250 0.3794 107.85 1.0000 45 f{C9H20N1O1}/-0.09ppm,p
  159.0998641 135.8368 159.100190 0.7040 12.32 0.1079 45 ?
  159.1573339 54.9742 159.157660 1.2818 16.79 0.7405 38 ?
PK$NUM_PEAK: 40
PK$PEAK: m/z int. rel.int.
  55.054422 35.53 35
  55.934668 314.64 314
  57.070134 110.52 110
  69.069947 32.84 32
  70.028817 45.07 45
  71.929387 31.26 31
  72.044507 335.72 335
  72.937238 142.43 142
  74.930865 43.82 43
  74.937650 179.04 179
  75.055350 30.16 30
  75.935441 32.06 32
  76.932983 72.91 72
  78.997088 104.67 104
  89.939794 36.41 36
  90.947630 55.08 55
  91.054210 23.04 23
  92.948048 28.68 28
  97.007612 146.14 146
  97.064723 31.90 31
  102.091347 222.64 222
  106.991947 147.10 147
  107.950413 39.55 39
  113.963673 34.44 34
  114.054984 105.84 105
  115.964055 211.77 211
  117.069814 40.45 40
  117.959532 83.62 83
  125.002520 232.32 232
  125.961050 33.05 33
  128.950783 172.14 172
  133.974583 44.41 44
  135.945337 81.32 81
  146.961318 84.03 84
  153.955908 45.39 45
  157.133590 27.26 27
  158.096437 999.00 999
  158.153927 463.68 463
  159.099864 135.84 135
  159.157334 54.97 54
//
